Brown-Forman beats by $0.03, reports revs in-line (56.04)
- Reports Q3 (Jan) earnings of $0.44 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus of $0.41; revenues rose 8.7% year/year to $878 mln vs the $870.06 mln Capital IQ Consensus.
- Reaffirming underlying outlook for net sales growth of 6-7% and operating income of 8-9%, and adjusting our EPS range to account for tax reform and related items.Co issues guidance for FY18, sees EPS of $1.43-1.48 (Prior $1.52-1.58), may not be comparable to $1.61 Capital IQ Consensus Estimate. The prior EPS is split -adjusted.
BF.B by International Markets
- Year-to-date underlying net sales grew 5% (+7% reported) in the United States.
- Sales in the company's developed markets outside of the United States remained robust, delivering year-to-date underlying net sales growth of +6% (+9% reported).
- The United Kingdom and Germany grew underlying net sales by +6% (+10% reported) and +11% (+16% reported), respectively.
- Australia's underlying net sales jumped 10% (+10% reported).
- Japan was the only one of our top ten markets that declined, due primarily to volume declines in Early Times.
- France's underlying net sales increased +5% (+10% reported).
- Canada grew +2% (+4% reported).
- Spain saw double-digit year-to-date underlying net sales growth.
- The company's two largest emerging markets, Mexico and Poland, both grew underlying net sales by 10% (+13% and +25% reported, respectively),
- Russia, Turkey, Brazil, Thailand, China and Ukraine grew underlying net sales well into the double-digits.